Skip to content

Public FDA record

Z-0556-2016: Granada Biphasic Broth The product is a selective medium for the screening and identification of Strepto

Recall record Z-0556-2016 for Biomerieux Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0556-2016
Company in FDA record
Biomerieux Inc
FDA classification date
Dec 29, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.

Source facts

Action
The firm, Biomerieux, sent an "Urgent Product Removal Notice" dated November 23, 2015 to its consignees. The letter described the product, problem and actions to be taken. The consignees were instructed to confirm that the letter has been distributed and reviewed by all appropriate personnel, discontinue and discard any remaining inventory, store letter with your bioMerieux documentation and complete the attached Acknowledgement Form via fax to: (919) 620-3306 attention of: bioMerieux NA ComOps QA/RA. If you have any questions or concerns, please contact your local bioMrieux Clinical Customer Service organization at (800) 682-2666.
Initiated
2015-11-23
Root cause
No Marketing Application
Terminated
2016-02-24
Distribution
US Distribution to states of: CA, GA, IN, MA, MN, MO, NY, OH and PA.
Recall number
Z-0556-2016
Recall status
Terminated
CDRH record ID
142164
FDA classified
2015-12-29
Recall event number
72760

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗